CCL19 and neoplasm: Our previous studies indicated that gene modification to express IL‐7 and CCL19 in antitumor effector T cells, such as CAR‐T and TCR‐T cells, profoundly enhances therapeutic effects for solid cancers by inducing a massive infiltration of immune cells in tumor tissues and long‐term memory responses.9, 10, 11